Financials
- Market Capitalization 462.87 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-10.57
売上高対価格比率
22.24
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.64 USD | -1.55% | +5.96% | +20.70% | -20.42% | 471.78 M USD | ||
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.56 USD | +0.65% | -17.89% | -6.02% | -25.00% | 471.21 M USD | ||
| 2987 | SLN Silence Therapeutics Plc - American Depository Share | 10.27 USD | +5.33% | +8.45% | +52.15% | +58.73% | 485.10 M USD | ||
| 2988 | RZLT Rezolute, Inc. - Common Stock | 4.74 USD | -1.86% | -1.66% | +8.97% | -7.06% | 456.43 M USD |